The reduced form of glutathione appears to demonstrate optimal bioavailability and potent antioxidant capabilities in laboratory settings
Participants were randomized to receive either 9 weeks of semaglutide or placebo
Nausea, vomiting, and diarrhea were typically the most common gastrointestinal adverse events, occurring in up to 48.4%, 23.2%, and 23.1% of participants, respectively, with events occurring predominantly during dose escalation and decreasing over time [10, 37, 43, 45,46,47]
By minimising fat accumulation and improving metabolic markers, it helps patients feel more energised and supports better long-term health
Notably, mitochondrial dysfunction induces endoplasmic reticulum (ER) stress, excessive reactive oxygen species (ROS) production, aberrant autophagy, apoptosis, and disrupted calcium ion homeostasis, culminating in inflammatory imbalance via activated signaling cascades [13,14,15,16,17]